Variable n (%) | No resection n = 142 | Resection n = 58 | P value |
---|---|---|---|
Preoperative variables | |||
Male sex | 83 (58.4) | 39 (67,2) | 0,247 |
Age years, median IQR | 58 (48–66) | 56 (48–66) | 0,969 |
Diabetes | 9 (6,3) | 1 (1,7) | 0,287 |
Dyslipidemia | 18 (12,7) | 11 (18,9) | 0,252 |
Dialysis | 2 (1,4) | 3 (5,2) | 0,147 |
Hypertension | 59 (41,5) | 20 (34,5) | 0,354 |
COPD | 7 (4,9) | 4 (6,9) | 0,580 |
Creatinine | 1 (0,9-1,08) | 0,95 (0,9–1) | 0,821 |
Previous myocardial infarction | 0 | 3 (5,2) | 0,023 |
Previous cardiac operation | 4 (2.8) | 1 (1,7) | 0,999 |
NYHA functional class | 0,079 | ||
I | 12 (8,7) | 9 (17,3) | |
II | 99 (72,3) | 36 (69,2) | |
III | 26 (19) | 7 (13,5) | |
Previous arrhythmia | 48 (33,8) | 19 (32,8) | 0,887 |
LVEF, median IQR | 55 (50–60) | 60 (51–65) | 0,013 |
Perioperative variables | |||
Isolated ring annuloplasty | 14 (9,8) | 0 (0,0) | < 0,001 |
Isolated MV repair | 107 (75) | 49 (84,5) | 0,108 |
Non-Isolated MV repair | 35 (25) | 9 (15,5) | 0,235 |
ASD closure | 7 (4,9) | 0 (0,0) | 0,086 |
Tricuspid repair | 24 (16,9) | 9 (15,5) | 0,809 |
Tricuspid replacement | 1 (0,7) | 0 (0,0) | 0,001 |
Tricuspid repair+ASD closure | 3 (2,1) | 0 (0,0) | 0,013 |
Minimally invasive | 51 (35,9) | 7 (12.1) | < 0,001 |
ICU stay days | 1 (1–4) | 1 (1–3) | 0,495 |
Post ICU stay (days) | 3 (2–5) | 4 (3–5) | 0,674 |
Degenerative MV pathology | |||
Posterior leaflet prolapse | 47 (33,1) | 35 (60,3) | 0,004 |
Anterior leaflet prolapse | 23 (16,1) | 4 (6,8) | 0,079 |
Bileaflet prolapse | 17 (11,9) | 3 (5,1) | 0,144 |
Elongated/ruptured chord(s) | 29 (20,4) | 10 (17,2) | 0,604 |
Annular dilation | 25 (17,6) | 2 (3,4) | 0,014 |
Unknown | 1 (0,7) | 4 (6,9) | 0,011 |
Postoperative complications | |||
Reoperation for bleeding | 0 (0,0) | 2 (3,4) | 0,083 |
Renal impairment | 2 (1,4) | 0 (0,0) | 0,503 |
Hospital length of stay | 8 (5–15) | 8 (5–14) | 0,906 |
Mortality 30 days | 0 (0,0) | 0 (0,0) |